학술논문

Delayed SARS-CoV-2 Clearance in Patients with Obesity
Document Type
Academic Journal
Source
Infection and Drug Resistance. July 31, 2021, Vol. 14, p2823, 5 p.
Subject
China
Language
English
ISSN
1178-6973
Abstract
Objective: The present study aimed to investigate the correlation between obesity and virus persistence in patients with COVID-19. Design and Methods: A total of 57 patients with laboratory-confirmed COVID-19 were admitted to two clinical centers, and data were analyzed retrospectively. Among them, 18 patients with body mass index (BMI) [greater than or equal to] 25 kg/[m.sup.2] were diagnosed with obesity, and dynamics of viral replication were compared. Results: Eighteen patients were diagnosed with obesity. The correlations between BMI and white blood cell, C-reactive protein, and cycle threshold (Ct) values of ORF1ab were not significant (all P > 0.05). On day 7 after admission, virus clearance was achieved in 13 (33.3%) patients with BMI < 25 kg/[m.sup.2] and 5 (27.8%) patients with BMI [greater than or equal to] 25 kg/[m.sup.2] ([chi square] = 0.176, P =0.68). On day 14, the RNA tests were negative in 37 (94.9%) patients with BMI < 25 kg/[m.sup.2] and 13 (72.2%) patients with BMI [greater than or equal to] 25 kg/[m.sup.2] ([chi square] = 5.865, P = 0.03). Multivariable analysis showed that only BMI [greater than or equal to] 25 kg/[m.sup.2] (P = 0.02) was the independent risk factor for virus clearance on day 14. Conclusion: Obesity may affect the clearance of SARS-CoV-2, and BMI should be assessed in patients with COVID-19, although they are not seriously ill. Keywords: SARS-CoV2, COVID-19, body mass index, obesity, virus clearance
Introduction SARS-CoV-2 infection, also known as 2019-nCoV disease (COVID-19), poses a global threat to public health. (1) The virus with high infectivity can be transmitted person-to-person, and the number of [...]